Inventory and purchasing
Review overlapping SKUs, ordering cycles, storage and distribution across departments and sites.
EraDOCate | Healthcare Cost & Operational Efficiency
PATIENT SAFETY. OPERATING EFFICIENCY. FINANCIAL PERFORMANCE.
EraDOCate partners with hospitals, health systems and outpatient facilities to support infection prevention while pursuing lower operating expenses. We help your team evaluate fewer chemical products, simpler cleaning workflows and measurable net savings across every site of care.
Start with your role
A hospital CFO, infection prevention leader, environmental services director and procurement team evaluate different risks and costs. Select your priority to go directly to the relevant information.
EraDOCate works with these teams together. All adoption decisions require facility-specific evaluation of approved uses and measured costs.
The operational challenge
Many healthcare facilities stock overlapping environmental cleaning products, each with its own purchasing, dispensing, storage, training and documentation requirements. Reviewing these products together may uncover opportunities to simplify the program.
Review overlapping SKUs, ordering cycles, storage and distribution across departments and sites.
Identify repetitive product training, preparation steps and inconsistent environmental services workflows.
Create clear, label-based instructions for surface preparation, dilution, wet contact time and verification.
A practical example
A hypothetical hospital begins with six separate environmental cleaning and disinfection products for general environmental cleaning, routine surface disinfection and specific outbreak-response tasks. Its infection prevention and safety teams assess which needs a streamlined EraDOCate program can cover.
Illustrative current inventory
Separate chemical products
Potential consolidated approach
Core cleaning and disinfection configurations
2026 environmental policy & sustainable purchasing
Healthcare leaders are being asked to control purchasing costs, reduce unnecessary plastic waste and evaluate chemical exposure. EraDOCate offers an opportunity to review concentrated, controlled-dispensing cleaning and disinfection systems as part of a hospital's infection prevention and sustainability strategy.
Compare purchasing ready-to-use bottles and single-use wipes against concentrate and dispensing systems. Track containers purchased, packaging weight, delivery frequency and discarded product. Savings depend on real consumption and packaging data.
Review whether approved EraDOCator-60 disinfection protocols and the separately documented E60 CLEAN system replace selected existing products. Keep specialty disinfectants, instrument products and other controls where required.
Evaluate a PAA and hydrogen-peroxide chemistry program as an alternative to eligible quat-based workflows. Compare each product's hazard profile, workplace exposure controls, surface compatibility and environmental handling. No disinfectant is hazard-free.
SB 54 regulations took effect in May 2026. State goals include a 25% reduction in single-use plastic packaging by 2032. This is primarily a packaging producer-responsibility framework, not a requirement for hospitals to use a specific disinfectant.
CalRecycle policy details ↗Oregon's program began in 2025, while other states are implementing producer-funded packaging and recycling requirements. Hospitals benefit from asking vendors for better packaging, refill and waste data, even when producers bear the direct legal obligations.
Oregon DEQ program ↗Minnesota, Maine and Colorado restrict intentionally added PFAS in certain cleaning-product categories, subject to definitions and exceptions. Buyers should compare ingredient documentation. PFAS and quaternary ammonium compounds are different chemical classes.
Minnesota PFAS guidance ↗The EraDOCate daily-preparation approach
EraDOCator-60's accepted label calls for fresh disinfection solution daily, or sooner when visibly soiled, clouded or diluted. The operational advantage is a documented mixing, labeling and verification routine, combined with planned production volumes to reduce excess inventory and avoid unnecessary waste.
For Hospital-at-Home and home health, EraDOCate is exploring where targeted environmental cleaning fits. Any private-home application or reuse of prepared disinfectant after the daily preparation period requires a separate label, safety and workflow review before it is offered as a service.
Background resources: EPA source reduction hierarchy · Practice Greenhealth chemical management · EraDOCate current label and documents. Policy developments support comparative purchasing reviews, not automatic claims of plastic savings, safer chemistry, or reduced infection rates.
Across the continuum of care
Each environment needs its own protocols, infection prevention oversight and approved surface applications.
Hospitals & health systems
Evaluate patient room turnover, high-touch surface protocols, product inventory, dispensing and training across hospital departments and affiliated locations.
Ambulatory surgery centers
Assess approved environmental surface disinfection steps, preparation, wet contact time, staffing and consumable costs during room turnover. Never shorten a required cleaning or contact-time step.
Urgent care clinics
Standardize eligible examination and treatment-room environmental surfaces, document responsibilities and compare costs across multiple clinic locations.
Family medicine & primary care
Evaluate environmental cleaning supplies, storage, staff instruction and purchasing without replacing instrument reprocessing or procedure-specific infection controls.
Financial evaluation tool
Enter your current and proposed annual costs. This calculator estimates potential net annual savings and product reduction. It does not assume that replacing products automatically reduces infections or generates extra clinical revenue.
Enter annual operating revenue to see how the modeled net savings translate to operating-margin percentage points.
Example: 4 fewer SKUs per location, a 67% reduction.
Default amounts are hypothetical planning assumptions, not EraDOCate prices or verified outcomes. Enter your actual costs for meaningful results. Include all products that remain necessary, freight, supplies, PPE, dispensing, servicing, training, disposal and transition costs. Calculate labor savings only when they reduce real spending. Do not treat theoretical time released as realized savings.
The CSV contains your entered assumptions plus blank fields for purchasing, surface compatibility and pilot planning. It downloads in your browser without sending facility data to EraDOCate.
Share your current inventory and clinical requirements. We will help you review product fit, implementation costs and a measurable pilot. The calculator does not submit information to our team.
The EraDOCate configurations
The program separates routine cleaning, registered surface disinfection and outbreak protocols. These are not interchangeable instructions.
Cleaning configuration
A surfactant-assisted cleaning configuration with separate documentation. It is not represented as having the registered disinfectant's antimicrobial claims.
Review specifications →EPA-registered disinfection
Peracetic acid and hydrogen peroxide concentrate for approved hard, nonporous environmental surface applications. Dilution and required wet contact times depend on the label-listed use.
Review EPA documentation →Label-directed outbreak configuration
A separate dispensing and purchasing workflow using the registered concentrate at the label-directed outbreak concentration. It is not a separately registered disinfectant formulation.
Review the outbreak protocol →Federal policy awareness. Local financial realities.
Health systems are managing financial changes beyond the clinical setting. The One Big Beautiful Bill Act, enacted July 4, 2025, changes Medicaid financing and coverage rules. Separately, CMS is expanding outpatient payment options. EraDOCate wants to work with your leadership team to identify controllable environmental disinfection costs, protect care standards and support your operating-margin goals.
National context: CBO estimated a $1.1 trillion reduction in federal healthcare outlays over FY2025–2034 and 10 million additional uninsured people by 2034 under the law, compared with its January 2025 baseline. These projections are not a direct estimate of any individual hospital's revenue loss.
New eligibility and financing provisions may increase budget pressure and uncompensated-care exposure for some health systems. Their effects vary by state, payer mix and facility.
For 2027, CMS finalized removal of 637 services from the inpatient-only list and added 618 codes to ASC payment eligibility. Hospitals and ASCs have greater reason to evaluate consistent, efficient workflows across sites of care.
The law establishes $50 billion in state-directed rural health funding. Its focus on sustainable care delivery reinforces the value of measurable operating efficiency. Project eligibility depends on state programs.
Operating efficiency across every site of care
For healthcare leaders, patient protection and financial sustainability belong in the same strategy. We work with CFOs, supply chain leaders, environmental services, infection prevention and outpatient operations to evaluate controllable disinfection expenses. By reducing unnecessary product overlap and measuring actual cost changes, we aim to support safer care processes and stronger financial performance.
Identify overlapping environmental cleaning and disinfection products and evaluate which SKUs can be eliminated without compromising required uses.
Build consistent purchasing, dilution, training and verification workflows for hospitals, ASCs, urgent care and primary care.
Establish current costs, run a controlled pilot and measure verified net savings against your own operating expense and margin targets.
When verified operating expenses fall and revenue stays constant, operating income improves dollar for dollar. EraDOCate's role is to help find and validate those opportunities, not to promise a fixed savings percentage.
Policy references: Congressional Research Service, P.L. 119-21 healthcare provisions · CMS 2027 outpatient and ASC rule · CMS Rural Health Transformation Program. Federal policy does not require use of EraDOCate products. Results depend on each system's economics and approved product protocols.
A measurable rollout
A responsible product-consolidation project includes the clinical, safety and purchasing teams from the beginning.
List current products, volumes, pricing, surfaces, pathogens of concern and required specialty uses.
Check EPA directions, SDS, PPE, material compatibility, dispensing, facility requirements and staff readiness.
Run a limited site evaluation with documented cleaning protocols and a pre-defined measurement plan.
Compare spending, product inventory, adherence, staff feedback and safety before system expansion.
Evidence before procurement
Healthcare buyers should be able to review the underlying work and understand what was actually measured. These examples inform evaluation but do not guarantee similar outcomes for another facility.
The published evaluation reported that median ATP surface readings fell to zero after a one-minute EraDOCator-60 application in four evaluated areas, including the emergency department and medical-surgical unit. ATP readings are a cleanliness-related measure, not direct proof of fewer infections.
Read the study →Havenwood reports outbreak duration declining from 31 days in 2023 to 14 days in 2025. EraDOCate adoption began in 2024 and expanded alongside training and workflow changes. These observational results do not isolate the product's effect.
Review the facility account →Frequently asked questions
Prepare fresh registered disinfectant daily as directed. The current label includes a specific cleaning-reuse provision for prepared solution in certain mechanical food-contact sanitizing operations. That provision is not a general approval for reuse of 24-hour-old hospital disinfectant or for residential cleaning. Any proposed cleaning-only reuse or Hospital-at-Home application requires written technical and regulatory review, separate from registered disinfection claims.
No. Consolidation depends on the EPA label, surface compatibility, facility policies and specific procedures. Sterilants, instrument reprocessing products and certain specialty products have separate requirements and may still be necessary.
No. Contact time is one part of turnover. Required precleaning, wetting, drying, equipment preparation, staffing and patient safety steps remain in place. Any operational gain should be measured at the facility.
E60 CLEAN is a separate cleaning configuration with its own documentation. EraDOCator-60 is the registered surface disinfectant. E60 STAT is a higher-concentration outbreak-use configuration of the same registered concentrate, subject to its approved label.
No. The law changes healthcare financing and coverage rules, not disinfectant purchasing requirements. CMS outpatient payment reforms are separate. EraDOCate offers an optional, measurable approach to environmental disinfection cost control, subject to approved labeling and facility requirements.
Current product list, purchase prices, annual quantities, number of locations, existing dispensing equipment, staffing workflow, waste costs, safety requirements and available operational metrics.
We start by discussing your products, relevant surfaces, current costs and infection prevention requirements. If an evaluation is appropriate, your team and EraDOCate define a limited pilot and measurable criteria before making any system-wide purchasing recommendation.
Start with your current inventory
Bring us your current inventory, packaging and waste volumes, operating expense targets and environmental cleaning requirements. EraDOCate will work with finance, infection prevention, EVS and supply chain teams to assess product fit, establish a baseline and pursue measurable operating expense improvements.
This page is an educational and operational planning resource. Product selection and use require review by the facility's infection prevention, environmental services, occupational safety and procurement teams. Follow current EPA-accepted labeling, the applicable SDS, device manufacturer instructions and facility policy. No savings or clinical outcome is guaranteed.